Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

Valdecoxib

Name Valdecoxib
Supplier R&D Systems
Catalog 4206
Prices $159.00, $665.00
Sizes 10 mg, 50 mg
Cas Number 181695-72-7
Chemical Name 4-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonamide
Formula C16H14N2O3S
Molecular Weight 314.36
Purity >99%
Supplier Page Shop

Product References

4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and - 4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and

Talley JJ, Brown DL, Carter JS, Graneto MJ, Koboldt CM, Masferrer JL, Perkins WE, Rogers RS, Shaffer AF, Zhang YY, Zweifel BS, Seibert K. J Med Chem. 2000 Mar 9;43(5):775-7.

A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by - A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by

Walker MC, Kurumbail RG, Kiefer JR, Moreland KT, Koboldt CM, Isakson PC, Seibert K, Gierse JK. Biochem J. 2001 Aug 1;357(Pt 3):709-18.

Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity. - Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.

Gierse JK, Zhang Y, Hood WF, Walker MC, Trigg JS, Maziasz TJ, Koboldt CM, Muhammad JL, Zweifel BS, Masferrer JL, Isakson PC, Seibert K. J Pharmacol Exp Ther. 2005 Mar;312(3):1206-12. Epub 2004 Oct 19.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved